Cargando…
Impact of the Trifecta bioprosthetic valve in patients with low-flow severe aortic stenosis
Aortic stenosis (AS) is the most common valve disorder in advanced age. Previous reports have shown that low-flow status of the left ventricle is an independent predictor of cardiovascular mortality after surgery. The Trifecta bioprosthesis has recently shown favorable hemodynamic performance. This...
Autores principales: | Takaseya, Tohru, Oryoji, Atsunobu, Takagi, Kazuyoshi, Fukuda, Tomofumi, Arinaga, Koichi, Hiromatsu, Shinichi, Tayama, Eiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260398/ https://www.ncbi.nlm.nih.gov/pubmed/33586008 http://dx.doi.org/10.1007/s00380-021-01802-5 |
Ejemplares similares
-
Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
por: Saku, Kosuke, et al.
Publicado: (2020) -
Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses
por: Lange, Rüdiger, et al.
Publicado: (2022) -
Florida sleeve technique for a right sinus of Valsalva aneurysm: a case report
por: Saku, Kosuke, et al.
Publicado: (2019) -
Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls
por: Mylonas, Konstantinos S., et al.
Publicado: (2023) -
Modes of failure of Trifecta aortic valve prosthesis
por: Malvindi, Pietro Giorgio, et al.
Publicado: (2022)